|
Rheumatoid Arthritis
Citations 481-490 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- MATTERS ARISING
Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis
- T. Cobo Ibáñez, M. Yehia Tayel, A. Balsa Criado, A. Hernández Sanz, and E. Martín Mola
Rheumatology 2005; 44: 1467-1468.
[Extract]
[Full Text]
- EDITORIALS
British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF- treatments
- J. Ledingham, C. Wilkinson, and C. Deighton
Rheumatology 2005; 44: 1205-1206.
[Extract]
[Full Text]
- EDITORIALS
Arthritis and inflammatory eye disease
- R. C. Bucknall
Rheumatology 2005; 44: 1207-1209.
[Extract]
[Full Text]
- REVIEWS
Complement and its breakdown products in SLE
- G. Sturfelt and L. Truedsson
Rheumatology 2005; 44: 1227-1232.
[Abstract]
[Full Text]
- BASIC SCIENCE
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes
- A. Del Rosso, M. Cinelli, S. Guiducci, A. Pignone, G. Fibbi, F. Margheri, A. Gabrielli, R. Giacomelli, A. Coppini, M. Del Rosso, and M. Matucci Cerinic
Rheumatology 2005; 44: 1255-1262.
[Abstract]
[Full Text]
- BASIC SCIENCE
PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population
- A. Martinez, A. Valdivia, D. Pascual-Salcedo, J. Ramón Lamas, M. Fernández-Arquero, A. Balsa, B. Fernández-Gutiérrez, E. G. de la Concha, and E. Urcelay
Rheumatology 2005; 44: 1263-1266.
[Abstract]
[Full Text]
- CLINICAL
The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project)
- A. Kastbom, A. Ahmadi, P. Söderkvist, and T. Skogh
Rheumatology 2005; 44: 1294-1298.
[Abstract]
[Full Text]
- CLINICAL
Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events
- K. T. Ho, C. W. Ahn, G. S. Alarcón, B. A. Baethge, F. K. Tan, J. Roseman, H. M. Bastian, B. J. Fessler, G. McGwin, Jr, L. M. Vilá, J. Calvo-Alén, J. D. Reveille, and for the LUMINA Study Group
Rheumatology 2005; 44: 1303-1307.
[Abstract]
[Full Text]
[ Supplementary data ]
- CLINICAL
Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events
- P. W. Thompson, L. Tee, J. McBride, D. Quincey, and G. Strat Liddiard
Rheumatology 2005; 44: 1308-1310.
[Abstract]
[Full Text]
- CLINICAL
Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy
- M. Y. Karim, C. N. Pisoni, L. Ferro, M. F. Tungekar, I. C. Abbs, D. P. D'Cruz, M. A. Khamashta, and G. R. V. Hughes
Rheumatology 2005; 44: 1317-1321.
[Abstract]
[Full Text]
|
|
